Citation Impact
Citing Papers
Trif-related adapter molecule is phosphorylated by PKCε during Toll-like receptor 4 signaling
2006
A single low dose of cadmium exposure induces benign prostate hyperplasia like condition in rat: A novel benign prostate hyperplasia rodent model
2014
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
The Herbicide Atrazine Activates Endocrine Gene Networks via Non-Steroidal NR5A Nuclear Receptors in Fish and Mammalian Cells
2008
Lipopolysaccharide signaling in endothelial cells
2005
Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways
2006 StandoutNobel
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial
2011
Erectile Dysfunction and Lower Urinary Tract
2008
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
2009
Inflammatory pathways in the mechanism of parturition
2007
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2011
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Mechanisms of endotoxin-induced NO, IL-6, and TNF-α production in activated rat hepatic stellate cells: Role of p38 MAPK
2006
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
2011
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2012
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
2012
Inflammatory pathways in female reproductive health and disease
2009
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Preterm labor: One syndrome, many causes
2014 StandoutScience
Neuroendocrine Mechanisms in Pregnancy and Parturition
2010
Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats
2011
Works of S. Oger being referenced
Combination of Alfuzosin and Tadalafil Exerts an Additive Relaxant Effect on Human Detrusor and Prostatic Tissues In Vitro
2009
Interleukin-1β Induces Phosphodiesterase 4B2 Expression in Human Myometrial Cells through a Prostaglandin E2- and Cyclic Adenosine 3′,5′-Monophosphate-Dependent Pathway
2002
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone‐supplemented spontaneously hypertensive rat
2012
Signalling pathways involved in sildenafil‐induced relaxation of human bladder dome smooth muscle
2010
A role for PKCζ in the LPS-induced translocation NF-κB p65 subunit in cultured myometrial cells
2005
Vardenafil Decreases Bladder Afferent Nerve Activity in Unanesthetized, Decerebrate, Spinal Cord–Injured Rats
2010
PDE4 as a target in preterm labour
2007
Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue
2008
Evidence for a Role of Phosphodiesterase 4 in Lipopolysaccharide-Stimulated Prostaglandin E2 Production and Matrix Metalloproteinase-9 Activity in Human Amniochorionic Membranes
2005
PDE5 GENE EXPRESSION AND RELAXANT EFFECTS OF VARDENAFIL IN MALE AND FEMALE HUMAN AND RAT DETRUSOR MUSCLE
2008
130 VARDENAFIL DECREASES BLADDER AFFERENT NERVE ACTIVITY IN UNANESTHETIZED DECEREBRATE SPINAL CORD-INJURED RATS
2010